121 related articles for article (PubMed ID: 37352081)
1. Is the serum level of survivin, an antiapoptotic protein, a potential predictive and prognostic biomarker in metastatic pancreatic cancer?
Demirci NS; Çavdar E; Erdem GU; Hatipoglu E; Celik E; Sezer S; Yolcu A; Dogan M; Seber ES
Medicine (Baltimore); 2023 Jun; 102(25):e34014. PubMed ID: 37352081
[TBL] [Abstract][Full Text] [Related]
2. Is plasma caveolin-1 level a prognostic biomarker in metastatic pancreatic cancer?
Demirci NS; Dogan M; Erdem GU; Kacar S; Turhan T; Kilickap S; Cigirgan LC; Kayacetin E; Bozkaya Y; Zengin N
Saudi J Gastroenterol; 2017; 23(3):183-189. PubMed ID: 28611342
[TBL] [Abstract][Full Text] [Related]
3. Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?
Bozkaya Y; Özdemir NY; Sezer S; Köstek O; Demirci NS; Yazıcı O; Erdem GU; Eren T; Zengin N
Cancer Biomark; 2018; 22(1):143-149. PubMed ID: 29562501
[TBL] [Abstract][Full Text] [Related]
4. Survivin expression and serum levels in pancreatic cancer.
Dong H; Qian D; Wang Y; Meng L; Chen D; Ji X; Feng W
World J Surg Oncol; 2015 May; 13():189. PubMed ID: 26016480
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum survivin in patients with pancreatic ductal adenocarcinoma.
Ren YQ; Zhang HY; Su T; Wang XH; Zhang L
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3063-8. PubMed ID: 25392106
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Hong JY; Ryu KJ; Park C; Hong M; Ko YH; Kim WS; Kim SJ
Oncotarget; 2017 Feb; 8(8):13782-13791. PubMed ID: 28099151
[TBL] [Abstract][Full Text] [Related]
7. The effect of apoptotic activity, survivin, Ki-67, and P-glycoprotein expression on prognosis in pancreatic carcinoma.
Sagol O; Yavuzsen T; Oztop I; Ulukus C; Ylmaz U; Alakavuklar M; Karademir S; Obuz F; Astarcoğlu H; Astarcoglu I
Pancreas; 2005 May; 30(4):343-8. PubMed ID: 15841045
[TBL] [Abstract][Full Text] [Related]
8. The combination of strong immunohistochemical mtTFA expression and a high survivin index predicts a shorter disease-specific survival in pancreatic ductal adenocarcinoma.
Kimura T; Kitada S; Uramoto H; Zhi L; Kawatsu Y; Takeda T; Horie S; Nabeshima A; Noguchi H; Sasaguri Y; Izumi H; Kohno K; Yamada S
Histol Histopathol; 2015 Feb; 30(2):193-204. PubMed ID: 25108120
[TBL] [Abstract][Full Text] [Related]
9. High expression of survivin is prognostic of shorter survival but not predictive of adjuvant gemcitabine benefit in patients with resected pancreatic adenocarcinoma.
Xie H; Jiang W; Xiao SY; Liu X
J Histochem Cytochem; 2013 Feb; 61(2):148-55. PubMed ID: 23124118
[TBL] [Abstract][Full Text] [Related]
10. High nuclear Survivin expression as a poor prognostic marker in pancreatic ductal adenocarcinoma.
Zhou L; Lu J; Liang ZY; Zhou WX; Yuan D; Li BQ; You L; Guo JC; Zhao YP
J Surg Oncol; 2018 Dec; 118(7):1115-1121. PubMed ID: 30261114
[TBL] [Abstract][Full Text] [Related]
11. Survivin expression as an independent predictor of overall survival in pancreatic adenocarcinoma.
Contis J; Lykoudis PM; Goula K; Karandrea D; Kondi-Pafiti A
J Cancer Res Ther; 2018 Sep; 14(Supplement):S719-S723. PubMed ID: 30249893
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of survivin in pancreatic endocrine tumors.
Ekeblad S; Lejonklou MH; Stålberg P; Skogseid B
World J Surg; 2012 Jun; 36(6):1411-8. PubMed ID: 22089920
[TBL] [Abstract][Full Text] [Related]
13. Survivin and aven: two distinct antiapoptotic signals in acute leukemias.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Sahin B; Burgut R
Ann Oncol; 2003 Jul; 14(7):1045-50. PubMed ID: 12853345
[TBL] [Abstract][Full Text] [Related]
14. Quantitatively determined survivin expression levels are of prognostic value in human gliomas.
Chakravarti A; Noll E; Black PM; Finkelstein DF; Finkelstein DM; Dyson NJ; Loeffler JS
J Clin Oncol; 2002 Feb; 20(4):1063-8. PubMed ID: 11844831
[TBL] [Abstract][Full Text] [Related]
15. Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients.
Tonini G; Vincenzi B; Santini D; Scarpa S; Vasaturo T; Malacrino C; Coppola R; Magistrelli P; Borzomati D; Baldi A; Antinori A; Caricato M; Nuzzo G; Picciocchi A
Br J Cancer; 2005 Jun; 92(12):2225-32. PubMed ID: 15928668
[TBL] [Abstract][Full Text] [Related]
16. Molecular detection of survivin expression, antiapoptotic gene, and other prognostic markers, how they are correlated and how it could be of prognostic value in chronic myeloid leukemia patient.
Zhara M; Mourad H; Farouk G; Elbatch M; Ezzat S; Sami W
Egypt J Immunol; 2007; 14(2):51-62. PubMed ID: 20306657
[TBL] [Abstract][Full Text] [Related]
17. Serum and urine survivin levels in breast cancer.
Guney N; Soydine HO; Derin D; Tas F; Camlica H; Duranyildiz D; Yasasever V; Topuz E
Med Oncol; 2006; 23(3):335-9. PubMed ID: 17018890
[TBL] [Abstract][Full Text] [Related]
18. Correlation of local and systemic expression of survivin with histopathological parameters of cutaneous melanoma.
Jović M; Cerović S; Zolotarevska L; Gačević M; Stanojević I; Miller K; Đukić M; Saso L; Jauković L; Vojvodić D
Vojnosanit Pregl; 2016 Nov; 73(11):1022-9. PubMed ID: 29328641
[TBL] [Abstract][Full Text] [Related]
19. Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma.
Goričar K; Kovač V; Franko A; Dodič-Fikfak M; Dolžan V
Dis Markers; 2015; 2015():316739. PubMed ID: 26451067
[TBL] [Abstract][Full Text] [Related]
20. Survivin--prognostic tumor biomarker in human neoplasms--review.
Waligórska-Stachura J; Jankowska A; Waśko R; Liebert W; Biczysko M; Czarnywojtek A; Baszko-Błaszyk D; Shimek V; Ruchała M
Ginekol Pol; 2012 Jul; 83(7):537-40. PubMed ID: 22880480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]